INCA036978 Clinical Trials (2026): 1 Studies for Myeloproliferative Neoplasms
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 INCA036978 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Myeloproliferative Neoplasms) and 218 total planned enrollment. 1 INCA036978 clinical trial is actively recruiting. Most recent activity: NCT07441694 (May 2030).
INCA036978 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting INCA036978 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07441694 | Study of INCA036978 in Participants With Myeloproliferative Neoplasms | P1 | Myeloproliferative Neoplasms | 218 | May 2026 |
All INCA036978 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07441694 | Study of INCA036978 in Participants With Myeloproliferative Neoplasms | P1 | recruiting | 218 | Incyte Corporation | May 2026 |
INCA036978 clinical trials: frequently asked questions
- How many INCA036978 clinical trials are there?
- 1 INCA036978 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are INCA036978 clinical trials recruiting in 2026?
- Yes — 1 INCA036978 trial is actively recruiting in 2026. See the recruiting trials and the per-state site list further down this page.
- What conditions is INCA036978 being studied for?
- INCA036978 is being studied for Myeloproliferative Neoplasms. The trials are grouped by indication on this page.
- What phase is INCA036978 in?
- INCA036978 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors INCA036978 clinical trials?
- The lead sponsor across the most INCA036978 trials is Incyte Corporation. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming INCA036978as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: